Hiroaki Koya
Overview
Explore the profile of Hiroaki Koya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanamori S, Koya H, Kurata N, Ishino K
Ann Nutr Metab
. 2025 Feb;
:1-10.
PMID: 39907997
Introduction: Enteral nutrition is used in patients with stroke, head-and-neck or esophageal cancer surgery, or repeated aspiration pneumonia. Japanese enteral nutrition guidelines recommend percutaneous endoscopic gastrostomy tube (PEG) for long-term...
2.
Hayashi Y, Momo K, Ando M, Koya H, Nagai T, Shinmura K, et al.
Int J Clin Pharmacol Ther
. 2024 Sep;
62(11):538-542.
PMID: 39239685
The global emergence of -COVID-19 has prompted rapid therapeutic and vaccine advancements; however, clinical evidence remains limited. With around a 50% fatality rate for COVID-19 patients with acute respiratory distress...
3.
Koya H, Ishino K, Kishimoto M, Kurata N
Ann Nutr Metab
. 2022 Jun;
78(4):207-212.
PMID: 35728557
Introduction: International standards for enteral feeding involving the use of feeding tubes with junctions have been introduced. If these junctions are not properly cleaned, they can become contaminated, leading to...
4.
Nagai T, Kurihara T, Koya H, Nakano Y, Sugisawa S, Sambe T, et al.
Neuropsychopharmacol Rep
. 2022 Apr;
42(3):249-255.
PMID: 35485452
Aim: Atomoxetine (ATX) is a non-central stimulant and a standard treatment for adult attention-deficit/hyperactivity disorder (ADHD). The long-term efficacy of Atomoxetine is about 40% at 6 months. The variability in...
5.
Sugisawa S, Kurihara T, Nakano Y, Tsuneoka T, Koya H, Nagai T, et al.
Neuropsychopharmacol Rep
. 2022 Jan;
42(1):77-83.
PMID: 35080152
Background: We conducted a historical cohort study of patients with schizophrenia to identify more robust risk factors at discharge that contribute to readmission within a year. Methods And Findings: The...
6.
Sugisawa S, Nozue S, Kurihara T, Koya H, Tsuneoka T, Nagai T, et al.
Perspect Psychiatr Care
. 2020 Feb;
56(3):720-725.
PMID: 32103521
Purpose: To identify factors for choking in psychiatric wards that can be easily screened. Design And Methods: Data were collected from patients admitted to the acute phase psychiatric wards who...